Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00676715
Brief Title: A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

First Submitted : May 9, 2008
First Submitted that Met QC Criteria : May 9, 2008
First Posted : May 13, 2008 (Estimate)

Results First Submitted : March 31, 2017
Results First Submitted that Met QC Criteria : March 31, 2017
Results First Posted : May 11, 2017

Certification/Extension First Submitted : March 25, 2013
Certification/Extension First Submitted that Met QC Criteria : March 25, 2013
Certification/Extension First Posted : April 1, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : September 23, 2019
Last Update Posted : September 25, 2019